2-(2,6-dioxopiperidin-3-yl)phthalimidine has been researched along with Congenital Limb Deformities in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krowke, R; Neubert, D | 1 |
| Heger, W; Merker, HJ; Neubert, D; Sames, K; Stürje, H | 1 |
2 other study(ies) available for 2-(2,6-dioxopiperidin-3-yl)phthalimidine and Congenital Limb Deformities
| Article | Year |
|---|---|
Effect of thalidomide-derivatives on limb development in culture.
Topics: Abnormalities, Drug-Induced; Animals; Biotransformation; Extremities; Female; Limb Deformities, Congenital; Mice; Mice, Inbred Strains; Microsomes, Liver; Organ Culture Techniques; Pregnancy; Procollagen-Proline Dioxygenase; Thalidomide | 1983 |
Embryotoxic effects of thalidomide-derivatives in the non-human primate Callithrix jacchus. I. Effects of 3-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-dioxopiperidine (EM12) on skeletal development.
Topics: Abnormalities, Drug-Induced; Animals; Bone and Bones; Callithrix; Dose-Response Relationship, Drug; Facial Bones; Female; Gestational Age; Limb Deformities, Congenital; Male; Pregnancy; Skull; Species Specificity; Thalidomide | 1988 |